FDA
-
-
-
-
-
-
-
Opus Genetics advances LCA5 gene therapy toward pivotal trial after FDA meeting
-
-
-
-
-
-
-
Opus Genetics doses first patient in phase 3 trial for vision solution
-
-
-
-
-
-
-
Opus Genetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
-
-
-
-
-
-
Opus Genetics Announces Presentations on Inherited Retinal Disease Programs at Medical Conferences in May
-
-
-
-
-
-
-
Opus Genetics to Participate in Upcoming Investor Conference in April
-
-
-
-
-
-
-
Opus Genetics (IRD) reports inducement awards
-
-
-
-
-
-
-
Shareholder Group Led by Founder Mina Sooch Nominates Majority Slate of Director Candidates to the Board of Opus Genetics, Inc.
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

